
Journal Menu
► ▼ Journal Menu-
- JPM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
30 May 2024
Journal of Personalized Medicine | Most Viewed Special Issues in 2022–2023 in Section “Methodology, Drug and Device Discovery”

We are pleased to invite you to read the most viewed Special Issues from 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in Section “Methodology, Drug and Device Discovery”. We hope this announcement will provide useful information for those working in this field.
The Special Issue list is as follows:
![]() |
![]() |
“Personalized and Precision Medicine 2022” |
“Personalized Radiotherapy” |
![]() |
![]() |
“Computer Assisted Maxillo-Facial Surgery” |
“Cutting-Edge in Arthroplasty: Before, While and after Surgery” |
You are welcome to view all of the Special Issues and submit relevant papers to the Journal of Personalized Medicine. If you have any questions, you can contact the Editorial Office at jpm@mdpi.com.
Journal of Personalized Medicine Editorial Office
30 May 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in Section “Regenerative Medicine and Therapeutics”

We are pleased to invite you to read the most viewed papers in 2022–2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Regenerative Medicine and Therapeutics”. The list of papers is as follows:
1. “Personalized Treatment Decisions for Traumatic Proximal Finger Amputations: A Retrospective Cohort Study”
by Nadjib Dastagir, Doha Obed, Khaled Dastagir and Peter M. Vogt
J. Pers. Med. 2023, 13(2), 215; https://doi.org/10.3390/jpm13020215
Available online: https://www.mdpi.com/2075-4426/13/2/215
2. “Lipedema Research—Quo Vadis?”
by Anna M. Ernst, Hannelore Bauer, Hans-Christian Bauer, Marianne Steiner, Anna Malfertheiner and Anna-Theresa Lipp
J. Pers. Med. 2023, 13(1), 98; https://doi.org/10.3390/jpm13010098
Available online: https://www.mdpi.com/2075-4426/13/1/98
3. “Modified Keystone Perforator Island Flap Techniques for Small- to Moderate-Sized Scalp and Forehead Defect Coverage: A Retrospective Observational Study”
by Byung-Woo Yoo, Kap-Sung Oh, Junekyu Kim, Hyun-Woo Shin and Kyu-Nam Kim
J. Pers. Med. 2023, 13(2), 329; https://doi.org/10.3390/jpm13020329
Available online: https://www.mdpi.com/2075-4426/13/2/329
4. “Treatment of Complex Wounds with NovoSorb® Biodegradable Temporising Matrix (BTM)—A Retrospective Analysis of Clinical Outcomes”
by Frederik Schlottmann, Doha Obed, Alperen S. Bingöl, Vincent März, Peter M. Vogt and Nicco Krezdorn
J. Pers. Med. 2022, 12(12), 2002; https://doi.org/10.3390/jpm12122002
Available online: https://www.mdpi.com/2075-4426/12/12/2002
5. “Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver”
by Roberto Minici, Raffaele Serra, Marco Giurdanella, Marisa Talarico, Maria Anna Siciliano, Gianpaolo Carrafiello and Domenico Laganà
J. Pers. Med. 2023, 13(4), 640; https://doi.org/10.3390/jpm13040640
Available online: https://www.mdpi.com/2075-4426/13/4/640
6. “A Randomized Controlled Trial of Three Advanced Wound Dressings in Split-Thickness Skin Grafting Donor Sites—A Personalized Approach?”
by Andrzej Hecker, David Benjamin Lumenta, Petra Brinskelle, Isabelle Sawetz, Andreas Steiner, Birgit Michelitsch, Herwig Friedl, Daniel Gmainer, Lars-Peter Kamolz and Raimund Winter
J. Pers. Med. 2022, 12(9), 1395; https://doi.org/10.3390/jpm12091395
Available online: https://www.mdpi.com/2075-4426/12/9/1395
7. “Efficacy and Safety of Axiostat® Hemostatic Dressing in Aiding Manual Compression Closure of the Femoral Arterial Access Site in Patients Undergoing Endovascular Treatments: A Preliminary Clinical Experience in Two Centers”
by Roberto Minici, Raffaele Serra, Claudio Maglia, Giuseppe Guzzardi, Marco Spinetta, Federico Fontana, Massimo Venturini and Domenico Laganà
J. Pers. Med. 2023, 13(5), 812; https://doi.org/10.3390/jpm13050812
Available online: https://www.mdpi.com/2075-4426/13/5/812
8. “Risk Stratification of Local Flaps and Skin Grafting in Skin Cancer-Related Facial Reconstruction: A Retrospective Single-Center Study of 607 Patients”
by Frederik Penzien Wainer Mamsen, Claes Hannibal Kiilerich, Jørgen Hesselfeldt-Nielsen, Iselin Saltvig, Celine Lund-Nielsen Remvig, Hannah Trøstrup and Volker-Jürgen Schmidt
J. Pers. Med. 2022, 12(12), 2067; https://doi.org/10.3390/jpm12122067
Available online: https://www.mdpi.com/2075-4426/12/12/2067
9. “Comparative Evaluation of Tissue Adhesives and Sutures in the Management of Facial Laceration Wounds in Children”
by Yu-Chi Tsai, Dun-Wei Huang, Yu-Yu Chou, Yu-Chin An, Yung-Sheng Cheng, Po-Huang Chen and Yuan-Sheng Tzeng
J. Pers. Med. 2023, 13(9), 1350; https://doi.org/10.3390/jpm13091350
Available online: https://www.mdpi.com/2075-4426/13/9/1350
10. “Does Electrical Stimulation through Nerve Conduits Improve Peripheral Nerve Regeneration?—A Systematic Review”
by Sophie Hasiba-Pappas, Lars-P. Kamolz, Hanna Luze, Sebastian P. Nischwitz, Judith C. J. Holzer-Geissler, Alexandru Cristian Tuca, Theresa Rienmüller, Mathias Polz, Daniel Ziesel and Raimund Winter
J. Pers. Med. 2023, 13(3), 414; https://doi.org/10.3390/jpm13030414
Available online: https://www.mdpi.com/2075-4426/13/3/414
23 May 2024
Transfer Service in MDPI
We are pleased to announce MDPI’s Transfer Service.
This service provides a convenient method of transferring your manuscript file, along with any reviewer comments, to another journal within our publishing portfolio.
We are committed to helping authors find the right home for their research, and we will provide authors with guidance and technical support through all stages of the transfer process. Authors will be able to choose to transfer in the following two situations:
1. Select alternative journals on submission.
2. Authors are encouraged to transfer manuscripts to other MDPI journals.
More details about the Transfer Service can be found at the following link:
17 May 2024
Tu Youyou Award—Open for Nominations
In acknowledgment of the groundbreaking achievements of Professor Tu Youyou, the Nobel laureate credited with the discovery of artemisinin, MDPI is proud to announce the Tu Youyou Award. This award, inaugurated in 2016, seeks to honor scholars who excel in the fields of natural products chemistry and medicinal chemistry.
Prize:
- CHF 100,000 in total (If there is more than one winner, the prize will be divided equally amongst the winners);
- An award medal for each winner.
Who should be nominated?
- Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.
Who can submit a nomination?
- Academic research institutes
- Universities
- Academic societies
Any personal nominations are not accepted.
How do I submit a nomination?
Candidates’ institutional affiliations need to submit their nominations for final candidates to the Tu Youyou Award Team directly by email after internal screening, and each institution can only nominate a maximum of two candidates for each edition of the Tu Youyou Award. Please note that the nominations cannot be modified once they are submitted and confirmed by the Tu Youyou Award Team.
Required nomination materials:
Nomination Form (Download)
Schedule:
Nomination deadline: 31 December 2024;
Winner announcement: 30 April 2025.
Contact:
Tu Youyou Award Team (tuyouyouaward@mdpi.com)
More information can be found on the Tu Youyou Award official website. For any inquiries, do not hesitate to contact the Tu Youyou Award Team.
16 May 2024
MDPI Romania Author Training Academic Events in April
MDPI Romania sponsored four events over the month of April, contributing author training sessions to each event.
The NutriSciLabs 2024 conference was held at the Carol Davila University of Medicine and Pharmacy on 12 April 2024. Organized by the Association of Students from the Faculty of Pharmacy Studies, the conference aimed to enhance students’ academic writing and research skills, and bolster their confidence in participating in the academic world. Ioana Paunescu, journal relations specialist for MDPI Romania, led the training session. Paunescu first outlined MDPI’s history and core values, then explained academic writing techniques, ethics, and similarity percentages. The presentation covered the entire editorial process, highlighting the amount of attention paid to details throughout manuscript processing. Paunescu also discussed common errors that authors make while writing, and how to avoid such errors.

On 13 April 2024, the NextGEN 2.0 Student Conference took place at the Babes-Bolyai University of Cluj-Napoca. NextGen Healthcare organized this event with the university’s European Students’ Society to discuss European and international current affairs. MDPI Romania contributed an author training session called Steps of the Publication Process. Irina Codruta Zaharia, journal relations specialist, began the session with a general introduction of MDPI before diving into different article types, different layout formats, possible journals to submit to, the MDPI submission checklist, and the MDPI editorial process. By explaining the fundamentals of writing and publishing academic papers, Zaharia imparted valuable industry knowledge to the curious minds present. Participants were eager to engage with Zaharia in the subsequent Q&A session.

Celebrating its 20th anniversary this year, the International Conference “Students for Students” has long been a gathering place for undergraduate and postgraduate students of all nationalities to present their work and exchange ideas with each other. This year’s conference was held on 18 April 2024, with MDPI Romania contributing an author training session called The World of Open Access. Key speakers included Dr. Norbert Kiss from MDPI Romania and Prof. Dragos Horvath from Strasbourg University. Dr. Kiss discussed the history of open access, differences between open access publishing and traditional publishing, and implications for open access in the future. Attendees expressed keen interest in the subject, approaching Dr. Kiss with questions about academic publishing as well as his career trajectory.

Most recently, on 26 April 2024, MDPI Romania sponsored the National Symposium of Students from Geology and Geophysics Faculties. The AAPG Students Chapter at the Babes-Bolyai University organized this event as an opportunity for geology students from all Romanian universities to present their work and confer with other researchers. Dr. Kiss gave his lecture The World of Open Access at this event as well.

MDPI is thankful to all the participants, speakers, and organizers who attended these events. Through their enthusiasm and dedication, these events were great successes.
8 May 2024
Meet Us at the 61st ERA Congress, 23–26 May 2024, Stockholm, Sweden

MDPI will be attending the 61st ERA Congress, which will be held from 23 to 26 May 2024 in Stockholm, Sweden.
The ERA Annual Congress remains committed to advancing the understanding and treatment of kidney disease to improve the well-being of patients. Our aim is to disseminate knowledge with a focus on clinical assessment and treatment, with the overarching theme for this year being “Rethinking Kidney Health and Transforming Kidney Care”. The ERA 2024 will also mark the 60th anniversary of the ERA Registry. Four special sessions (Creative Labs), organized by the ERA Registry group, will provide insight into their expertise and knowledge.
The following MDPI journals will be represented:
If you plan on attending this conference, feel free to stop by our booth. Our delegates look forward to meeting you in person to answer any questions you may have.
For more information about the conference, please visit the following link: https://era-shop.interplan.de/.
2 May 2024
MDPI Insights: The CEO's Letter #11 - 2023 Annual Report, MDPI Awards, STM

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2023 Annual Report
This is an exciting time of year at MDPI, as we have just released our annual report 2023, recapping the past year and sharing the progress and changes that took place during it.
Stefan Tochev (CEO, MDPI)
Reflecting on 2023, I can't help but think of the changes that have occurred not only at MDPI but also within our industry as a whole. In light of this, I’m reminded that change is the only constant, and that for a publishing enterprise that has experienced rapid growth, adapting to change becomes not only a necessity but also a catalyst for sustained success.
Looking back on the significant ground we covered in 2023, I am pleased to report that the year was marked by a rise in paper submissions, along with a range of initiatives aimed at improving our internal processes and delivering top services to our scientists.
2023 Top-line MDPI Numbers
An important priority for 2023 was to strengthen our editorial policies. Despite a notable increase in the number of papers submitted from 603,000 to 655,000 (+8.6%), there was a decrease in the number of papers published from 303,000 to 285,000 (-5.9%), consistent with the overall trend in the scholarly publishing market. MDPI’s market share in gold open access articles published reached 17% in 2023 (according to Dimensions data).
2023 Open Access Numbers
For over two decades, MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020. This trajectory is deeply rooted in our history and reflects our unwavering commitment to, and vision for, an open future. This momentum continued in 2023, with 39% of the 4.16 million articles and reviews published as gold full-OA, 15% as gold hybrid-OA, 8% as bronze-OA, and 3% as green-OA, relative to 35% behind a paywall. In terms of gold OA (full or hybrid) articles and reviews published, MDPI leads the way in terms of total articles published in 2023.
MDPI is the trusted and preferred OA publisher for the scholarly community
However, in 2023, we saw a downward trend in publication numbers compared to 2022. This trend was also seen in total OA publications. While the number of submissions increased, the decline in MDPI publications can be attributed to several factors, such as improved scrutiny in our peer-review process, including the evaluation of content scope and higher rejection rates, and a post-pandemic decrease in research related to COVID-19 papers.
Download 2023 MDPI Annual Report.
Access 2023 Digital Report.
Impactful Research
Recognizing Scholars – MDPI Awards
MDPI is committed to empowering young researchers as they embark on their careers. In 2023, our journals hosted a total of 400 awards, receiving 8,839 applications and nominations. The evaluation committees selected 959 winners, with the total budget for these awards amounting to CHF 546,500.
For more information about MDPI awards, applications, and winners, please click here
The following awards recognize scholars and the impact of their research, including Young Investigator Awards, Best PhD Thesis Awards, and Travel Awards for junior researchers.
MDPI Awards – The following awards require an application or a nomination.
Young Investigator Award (CHF 1000–2000 for each winner)
This award acknowledges the achievements of young investigators in research areas relevant to the journal’s scope. Candidates must have received their PhD no more than 10 years prior to the award announcement date and must be nominated.
Best PhD Thesis Award (CHF 500–800 for each winner)
This award recognizes young scholars who have completed outstanding PhD theses in research areas relevant to the journal’s scope. It aims to encourage them to continue their excellent work and make further contributions to their field.
Travel Award (CHF 500–800 for each winner)
This award encourages junior scientists to present their latest research at academic conferences relevant to the journal’s scope, thereby increasing their impact.
Distinguished Scholars
Additionally, 220 awards were granted to the most distinguished authors and reviewers in our journals through Best Paper Awards and Outstanding Reviewer Awards. The following awards are selected by the editorial staff of the journal and do not require an application or a nomination. They exemplify the excellent contributions made by our authors, reviewers, and editors.
These awards exemplify the excellent contributions made by our authors, reviewers, and editors
Best Paper Award (CHF 200–500 for each winner)
This award is granted annually to highlight publications of high quality, scientific significance, and extensive influence.
Outstanding Reviewer Award (CHF 500 for partial winners)
This award is given annually to recognize reviewers who generously contribute their time to reviewing papers and demonstrate thoroughness, professionalism, and timeliness in their reviews.
MDPI also offers awards for specific topics in various research fields:
Carbon Neutrality Award (CHF 500–800 for each winner)
Sponsored by MDPI journal Sustainability, this award recognizes applicants who have made exceptional academic or societal contributions to carbon neutrality, either in general or in relation to a specific carbon-neutrality-related issue.
Intelligent Manufacturing Award (CHF 500–800 for each winner)
Administered by MDPI journal Machines, this award is presented to an individual who has made outstanding academic or societal contributions to the field of intelligent manufacturing.
Granted: World Sustainability Awards
Inside MDPI
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
As CEO of the world’s leading OA publisher, I am pleased to announce the official opening of our Korean branch office. With this addition, MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher. This expansion represents more than just an increase in our physical footprint; it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible across the globe.
MDPI now operates 21 offices in 12 countries worldwide, improving on our position as a truly global publisher
Claude Seo (MDPI Korea Office Manager, Seoul)
Claude Seo, who has over 15 years of experience in the academic publishing industry, has been appointed as the Office Manager of the Seoul office. The launch of our Seoul office allows us to better support the Korean scientific community and to further promote the publication of OA journals in the region.
Reflecting on his role, Claude shared that he is:
“Delighted to have been entrusted with this position within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating ourselves into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
Additionally, I am pleased to share that Sungkyunkwan University has joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDP’s online submission system for institutions and provides APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyunghee University, Chung-Ang University, and the Catholic University of Korea, have adopted IOAP in Korea.
Learn more about MDPI’s collaboration in Korea in my previous CEO Letter, in which I recap our visit to Seoul, South Korea.
Coming Together for Science
4th MMCS: Harnessing the Power of New Drug Modalities
Our conference team successfully managed the 4th Molecules Medicinal Chemistry Symposium, held from 24–26 April in Barcelona, Spain. It was chaired by Prof. Dr. Diego Muñoz-Torrero from the Institute of Biomedicine (IBUB), University of Barcelona, Spain, and Prof. Dr. Simona Collina from the University of Pavia, Italy. In total, there were 84 accepted abstracts and 102 conference attendees from 22 different countries.
From left to right: Prof. Dr. Rino Ragno (Scientific Committee), Dr. Maria Emilia Sousa (Scientific Committee), Prof. Dr. Claudio Viegas Jr. (Scientific Committee), Prof. Dr. Simona Collina (Chair), Prof. Dr. Diego Muñoz-Torrero (Chair), Alvina Wu (Managing Editor, MDPI), Prof. Dr. Roman Dembinski (Scientific Committee), Prof. Dr. Mariana Spetea (Scientific Committee).
The event comprised 12 Invited Speakers, 35 Selected Talks, 10 Flash Poster Presentations, and 39 Posters. The overarching topic of the conference was the impact of the emergence of new drug modalities on drug discovery, with thematic sessions covering topics such as photoactivatable drugs, candidates targeting RNA and epigenetic targets, covalent modifiers, and the development of new anti-cancer agents, among other medicinal chemistry projects.
We are pleased to have received feedback from attendees highlighting the professional approach of the conference chairs and participants, the high quality of the talks, and the overall outstanding organization on the part of the MDPI conference team.
Thank you to the conference sponsors, Fluorochem and IBUB, and to our partnering societies, The Spanish Society for Biochemistry and Molecular Biology (SEBBM), and the Spanish Society of Medicinal Chemistry (SEQT).
Upcoming In-Person Event
28–31 May, 2024
Polymers 2024 – Polymers for a Safe and Sustainable Future
Location: Athens, Greece
Conference Chairs: Prof. Dr. Dimitrios Bikiaris, Prof. Dr. Konstantinos Triantafyllidis, Dr. Ioanna Deligkiozi
We look forward to welcoming experts Prof. Damià Barceló, Prof. Minna Hakkareinen, and Prof. Armando J. D. Silvestre to this event.
Find more upcoming MDPI events here.
Organize Your Event with MDPI’s Sciforum
Sciforum is MDPI’s platform dedicated to the organization of scientific events. In line with our mission to promote science, Sciforum supports scholars, societies, research networks, and universities at all stages of organizing in-person events, virtual events and webinars. Our platforms are efficient, user-friendly, and cost-effective. We handle all steps related to event management. Contact us for details.
Closing Thoughts
A Report from the Future – STM US Annual Conference 2024
Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board.
MDPI has for a long time been a sponsor of the STM Annual Conferences, held yearly in the US and Frankfurt, and is a trusted partner and supporter of the STM organization. While I have attended the Frankfurt conference for the past three years, this was my first time visiting the Washington, DC session, and I am glad I did.
Although it was a brief trip, I greatly appreciated the opportunity to attend in the company of my colleagues Dr. Giulia Stefenelli and Dr. Ioana Craciun from MDPI’s Scientific Office Board. They always help map some of the new industry trends against MDPI’s operational framework and guidelines. It’s a great group for kicking ideas back and forth on what we can apply at MDPI.
In my experience, STM never fails to deliver. It’s always a great conference for reconnecting with fellow publishers, industry friends, and vendors. As usual, STM this year curated a diverse range of speakers and panels, who proferred valuable knowledge and insights from outside our industry, delivering thought-provoking insights into our field. An example of this was the ‘Trust Panel’ session, which included Alan Schiffres (Managing Director, InfoLinx), who shared a number of the learnings about fraud and risk management from his 40 years in financial services, to help address some of the challenges we are currently facing in the area of publishing integrity.
Launch of STM Trends 2028 Panel
I particularly enjoyed the ‘Launch of STM Trends 2028 Panel’, which presented a report focused on the integration of humans and machines in scholarly publishing. The session highlighted themes such as AI, digitization, and the evolving research ecosystem. The report envisions a future where technology blurs the lines between human and machine involvement in research processes, with significant implications for trust, reputation, and equity. While this presents opportunities for connectivity and knowledge dissemination, it also poses challenges such as disinformation, fragmentation, and geopolitical tensions. We must rely on a wise combination of technology and human agency to navigate this complex landscape and will have to carefully examine its potential impacts on communication and scholarly publishing.
MDPI has joined the STM Integrity Hub. Click here to learn more.
While every presenter brought their own knowledge and personal touch, I was particularly pleased to encounter new speakers such as Heather Whitney (Research Assistant Professor, Radiology, University of Chicago) and Igor Grossmann (Professor of Psychology, University of Waterloo, Canada). Having studied Sociology at the University of Guelph, I have a soft spot for fellow social scientists from Canada, and I was very impressed by Igor’s presentation on ‘The Social Scientist: A View from the Future’ and his participation in the panel session ‘The Future Beyond the Article,’ which was one of my favourites from the conference, given the diversity of perspectives from the panel speakers.
Memorial Park in Washington, DC
On a personal note, this was my first-time visiting Washington, DC, and I’m glad we took an afternoon to visit the Memorial Park, with its incredible monuments to figures ranging from Martin Luther King, Jr. to Abraham Lincoln. The magnitude of the monuments is deeply impressive. I particularly appreciated the Thomas Jefferson memorial and the following quote, which I think speaks to the importance of change and adaptation. It’s something we can apply not only in our industry but also in our personal lives.
"I am not an advocate for frequent changes in laws and constitutions, but laws and institutions must go hand in hand with the progress of the human mind. As that becomes more developed, more enlightened, as new discoveries are made, new truths discovered and manners and opinions change, with the change of circumstances, institutions must advance also to keep pace with the times. We might as well require a man to wear still the coat which fitted him when a boy as a civilized society to remain ever under the regimen of their barbarous ancestors."
– Excerpted from a letter to Samuel Kercheval, July 12, 1816.
Chief Executive Officer
MDPI AG
30 April 2024
MDPI Opens Office in Seoul, Korea and Appoints Claude Seo as Office Manager
MDPI, the leading Open Access (OA) publisher, announced on Monday that it opened its Korean branch office on 29th April 2024. With this addition, MDPI now operates 21 offices in 12 countries worldwide. Claude Seo, with over 20 years of experience in the academic journal publishing industry, including Nature Publishing Group (NPG), has been appointed as the Office Manager of the Seoul office.
With the establishment of a Seoul office, MDPI aims to actively support Korea scientific communities to further promote the publication of OA journals in the region. As of the end of 2023, Korea ranked sixth worldwide in both submissions and publications of MDPI research papers. MDPI is the number one OA publisher in Korea.
Sungkyunkwan University Joins MDPI’s Institutional Open Access Program
In addition, MDPI announced that Sungkyunkwan University joined MDPI’s Institutional Open Access Program (IOAP). This program offers free access to MDPI online submission system for the institutions and APC discounts to affiliated authors. Thirteen major Korean universities, including Sungkyunkwan University, Kyung Hee University, Chung-Ang University and Catholic University of Korea, have adopted IOAP in Korea.
OA aims to break down barriers that have traditionally restricted access to science, ensuring that knowledge is available to all, regardless of financial situation or institutional affiliations. Authors, academia, and scientific communities are rapidly moving toward OA. MDPI has been at the forefront of reshaping the academic publishing landscape, with OA surpassing subscription-based publishing in 2020.
MDPI CEO Visits Seoul, Korea
In March, Stefan Tochev, Chief Executive Officer (CEO) of MDPI, visited Korea and met with various stakeholders including government agencies, research and academic institutions, universities. During his visit, Stefan highlighted that MDPI continues to pave the way for a world where science is accessible to all, supporting a global community of inclusive innovation and collaborative solutions.
Stefan expressed excitement about the new venture, stating, "Today marks a significant milestone for MDPI as we celebrate the opening of our new office in Seoul, Korea. This expansion is more than just an increase in our physical footprint, it is a pivotal step in our ongoing commitment to making scientific knowledge more accessible, participatory, and inclusive across the globe."
Claude Seo, reflecting on his new role, commented, "I am delighted to have been offered this position of trust within MDPI, the no. 1 scholarly OA publisher. As we establish our presence in Korea, we are dedicated to integrating into the local community and contributing to its vibrant culture. Our commitment goes beyond business growth; it is about creating a more informed and innovative society by embracing and promoting diversity within the scientific community.”
For further inquiries, please contact our Seoul office directly.
About MDPI
A pioneer in scholarly, open access publishing, MDPI has supported academic communities since 1996. MDPI is leading the transition to open science by making more research free and accessible to everyone. Over 3.3 million researchers have entrusted MDPI with publishing their scientific discoveries. MDPI’s editorial process is bolstered by a network of dedicated reviewers, a team of 6000 diligent, well-trained staff members, and an in-house article submission platform that was designed to ensure efficient processes within its 430 fully OA titles.
26 April 2024
Journal of Personalized Medicine | Most Cited Papers about Neurological Disease in 2022–2023

We are pleased to invite you to read the most cited papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) about neurological disease. We hope this announcement will provide useful information for this field.
1. “Artificial Intelligence-Driven Prediction Modeling and Decision Making in Spine Surgery Using Hybrid Machine Learning Models”
by Babak Saravi, Frank Hassel, Sara Ülkümen, Alisia Zink, Veronika Shavlokhova, Sebastien Couillard-Despres, Martin Boeker, Peter Obid and Gernot Michael Lang
J. Pers. Med. 2022, 12(4), 509; https://doi.org/10.3390/jpm12040509
Available online: https://www.mdpi.com/2075-4426/12/4/509
2. “Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases”
by Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti and Sebastiano Cavallaro
J. Pers. Med. 2022, 12(5), 770; https://doi.org/10.3390/jpm12050770
Available online: https://www.mdpi.com/2075-4426/12/5/770
3. “The Contribution of “Individual Participant Data” Meta-Analyses of Psychotherapies for Depression to the Development of Personalized Treatments: A Systematic Review”
by Pim Cuijpers, Marketa Ciharova, Soledad Quero, Clara Miguel, Ellen Driessen, Mathias Harrer, Marianna Purgato, David Ebert and Eirini Karyotaki
J. Pers. Med. 2022, 12(1), 93; https://doi.org/10.3390/jpm12010093
Available online: https://www.mdpi.com/2075-4426/12/1/93
4. “Pathophysiology, Classification and Comorbidities after Traumatic Spinal Cord Injury”
by James Guest, Nilanjana Datta, George Jimsheleishvili and David R. Gater
J. Pers. Med. 2022, 12(7), 1126; https://doi.org/10.3390/jpm12071126
Available online: https://www.mdpi.com/2075-4426/12/7/1126
5. “Should Neurosurgeons Try to Preserve Non-Traditional Brain Networks? A Systematic Review of the Neuroscientific Evidence”
by Nicholas B. Dadario and Michael E. Sughrue
J. Pers. Med. 2022, 12(4), 587; https://doi.org/10.3390/jpm12040587
Available online: https://www.mdpi.com/2075-4426/12/4/587
6. “Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials”
by Sudarshawn Damodharan, Montserrat Lara-Velazquez, Brooke Carmen Williamsen, Jeffrey Helgager and Mahua Dey
J. Pers. Med. 2022, 12(5), 840; https://doi.org/10.3390/jpm12050840
Available online: https://www.mdpi.com/2075-4426/12/5/840
7. “Autonomic Dysfunction and Management after Spinal Cord Injury: A Narrative Review”
by Austin M. Henke, Zackery J. Billington and David R. Gater
J. Pers. Med. 2022, 12(7), 1110; https://doi.org/10.3390/jpm12071110
Available online: https://www.mdpi.com/2075-4426/12/7/1110
8. “Microbiome Changes in Humans with Parkinson’s Disease after Photobiomodulation Therapy: A Retrospective Study”
by Brian Bicknell, Ann Liebert, Craig S. McLachlan and Hosen Kiat
J. Pers. Med. 2022, 12(1), 49; https://doi.org/10.3390/jpm12010049
Available online: https://www.mdpi.com/2075-4426/12/1/49
9. “Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases”
by Alessandro Trentini, Maria Cristina Manfrinato, Massimiliano Castellazzi and Tiziana Bellini
J. Pers. Med. 2022, 12(8), 1196; https://doi.org/10.3390/jpm12081196
Available online: https://www.mdpi.com/2075-4426/12/8/1196
10. “Post-Stroke Depression and Cognitive Aging: A Multicenter, Prospective Cohort Study”
by Minyoung Shin, Min Kyun Sohn, Jongmin Lee, Deog Young Kim, Yong-Il Shin, Gyung-Jae Oh, Yang-Soo Lee, Min Cheol Joo, So Young Lee, Min-Keun Song et al.
J. Pers. Med. 2022, 12(3), 389; https://doi.org/10.3390/jpm12030389
Available online: https://www.mdpi.com/2075-4426/12/3/389
11. “Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas”
by Mohammed Khamaysa and Pierre-François Pradat
J. Pers. Med. 2022, 12(10), 1601; https://doi.org/10.3390/jpm12101601
Available online: https://www.mdpi.com/2075-4426/12/10/1601
12. “The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration
by Anna Pisani, Fabiola Paciello, Valeria Del Vecchio, Rita Malesci, Eugenio De Corso, Elena Cantone and Anna Rita Fetoni
J. Pers. Med. 2023, 13(4), 652; https://doi.org/10.3390/jpm13040652
Available online: https://www.mdpi.com/2075-4426/13/4/652
13. “Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions”
by Giacomo d’Andrea, Gianluca Mancusi, Maria Chiara Santovito, Carlotta Marrangone, Fabrizio Martino, Mario Santorelli, Andrea Miuli, Francesco Di Carlo, Maria Salvina Signorelli, Massimo Clerici et al.
J. Pers. Med. 2023, 13(4), 697; https://doi.org/10.3390/jpm13040697
Available online: https://www.mdpi.com/2075-4426/13/4/697
14. “Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury”
by Sergio Haro Girón, Jorge Monserrat Sanz, Miguel A. Ortega, Cielo Garcia-Montero, Oscar Fraile-Martínez, Ana M. Gómez-Lahoz, Diego Liviu Boaru, Diego de Leon-Oliva, Luis G. Guijarro, Mar Atienza-Perez et al.
J. Pers. Med. 2023, 13(4), 626; https://doi.org/10.3390/jpm13040626
Available online: https://www.mdpi.com/2075-4426/13/4/626
15. “Age and Sex-Related Effects on Single-Subject Gray Matter Networks in Healthy Participants”
by Yoko Shigemoto, Noriko Sato, Norihide Maikusa, Daichi Sone, Miho Ota, Yukio Kimura, Emiko Chiba, Kyoji Okita, Tensho Yamao, Moto Nakaya et al.
J. Pers. Med. 2023, 13(3), 419; https://doi.org/10.3390/jpm13030419
Available online: https://www.mdpi.com/2075-4426/13/3/419
23 April 2024
Journal of Personalized Medicine | Most Viewed Papers in 2022–2023 in the Section “Personalized Critical Care”

We are pleased to invite you to read the most viewed papers in 2022 and 2023 in the Journal of Personalized Medicine (JPM, ISSN: 2075-4426) in the Section “Personalized Critical Care”. The list of papers is as follows:
by Victoriţa Şorodoc, Andreea Asaftei, Gabriela Puha, Alexandr Ceasovschih, Cătălina Lionte, Oana Sîrbu, Cristina Bologa, Raluca Ecaterina Haliga, Mihai Constantin, Adorata Elena Coman et al.
J. Pers. Med. 2023, 13(1), 140; https://doi.org/10.3390/jpm13010140
Available online: https://www.mdpi.com/2075-4426/13/1/140
2. “Non-Pharmacological Nursing Interventions to Prevent Delirium in ICU Patients—An Umbrella Review with Implications for Evidence-Based Practice”
by Sandra Lange, Wioletta Mędrzycka-Dąbrowska, Adriano Friganovic, Ber Oomen and Sabina Krupa
J. Pers. Med. 2022, 12(5), 760; https://doi.org/10.3390/jpm12050760
Available online: https://www.mdpi.com/2075-4426/12/5/760
3. “Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders”
by Anastasia Balta, Alexandr Ceasovschih, Victorița Șorodoc, Kyriakos Dimitriadis, Sara Güzel, Cătălina Lionte, Cristian Stătescu, Radu Andy Sascău, Emmanouil Mantzouranis, Athanasios Sakalidis et al.
J. Pers. Med. 2022, 12(11), 1754; https://doi.org/10.3390/jpm12111754
Available online: https://www.mdpi.com/2075-4426/12/11/1754
4. “Nurses’ Practices in the Peripheral Intravenous Catheterization of Adult Oncology Patients: A Mix-Method Study”
by Paulo Santos-Costa, Filipe Paiva-Santos, Liliana B. Sousa, Rafael A. Bernardes, Filipa Ventura, William David Fearnley, Anabela Salgueiro-Oliveira, Pedro Parreira, Margarida Vieira and João Graveto
J. Pers. Med. 2022, 12(2), 151; https://doi.org/10.3390/jpm12020151
Available online: https://www.mdpi.com/2075-4426/12/2/151
5. “Elements of Sleep Breathing and Sleep-Deprivation Physiology in the Context of Athletic Performance”
by Dimitra D. Papanikolaou, Kyriaki Astara, George D. Vavougios, Zoe Daniil, Konstantinos I. Gourgoulianis and Vasileios T. Stavrou
J. Pers. Med. 2022, 12(3), 383; https://doi.org/10.3390/jpm12030383
Available online: https://www.mdpi.com/2075-4426/12/3/383
6. “Dental and Skeletal Side Effects of Oral Appliances Used for the Treatment of Obstructive Sleep Apnea and Snoring in Adult Patients—A Systematic Review and Meta-Analysis”
by Ioannis A. Tsolakis, Juan Martin Palomo, Stefanos Matthaios and Apostolos I. Tsolakis
J. Pers. Med. 2022, 12(3), 483; https://doi.org/10.3390/jpm12030483
Available online: https://www.mdpi.com/2075-4426/12/3/483
7. “Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence”
by Rosa Méndez Hernández and Fernando Ramasco Rueda
J. Pers. Med. 2023, 13(2), 333; https://doi.org/10.3390/jpm13020333
Available online: https://www.mdpi.com/2075-4426/13/2/333
8. “Can Opioid-Free Anaesthesia Be Personalised? A Narrative Review”
by Jenna Goff, Morgan Hina, Nayaab Malik, Hannah McLardy, Finley Reilly, Matthew Robertson, Louis Ruddy, Faith Willox and Patrice Forget
J. Pers. Med. 2023, 13(3), 500; https://doi.org/10.3390/jpm13030500
Available online: https://www.mdpi.com/2075-4426/13/3/500
9. “The Effect of Interventions on Preventing Musculoskeletal Injuries Related to Nurses Work: Systematic Review”
by Armando David Sousa, Cristina Lavareda Baixinho, Maria Helena Presado and Maria Adriana Henriques
J. Pers. Med. 2023, 13(2), 185; https://doi.org/10.3390/jpm13020185
Available online: https://www.mdpi.com/2075-4426/13/2/185
10. “Medical/Surgical, Cloth and FFP/(K)N95 Masks: Unmasking Preference, SARS-CoV-2 Transmissibility and Respiratory Side Effects”
by Dimitra S. Mouliou, Ioannis Pantazopoulos and Konstantinos I. Gourgoulianis
J. Pers. Med. 2022, 12(3), 325; https://doi.org/10.3390/jpm12030325
Available online: https://www.mdpi.com/2075-4426/12/3/325